# Glycopyrrolate

NDC: 0641-6213
Generic name: Glycopyrrolate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20250828

FDA application: NDA017558

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0641-6213"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6213
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=960d2dd0-008d-4ec1-ba2e-9388b28b23e2